Antares Pharma Inc (ATRS):企業の財務・戦略的SWOT分析

◆英語タイトル:Antares Pharma Inc (ATRS) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1334
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Antares Pharma Inc (ATRS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Antares Pharma Inc (Antares Pharma) is a specialty pharmaceutical company that develops, manufactures, and commercializes self-administered parenteral pharmaceutical products and technologies. The company’s portfolio encompasses novel therapeutic products for the treatment of polyarticular juvenile idiopathic arthritis, adults with severe rheumatoid arthritis, severe recalcitrant psoriasis, migraine and cluster headache, and to reduce the risk of preterm birth in pregnant women. It caters its subcutaneous injection technology platforms to both generic and branded injectables. Antares Pharma’s injectables are available in disposable multi-dose pen injectors and unit dose containers. The company employs drug delivery systems to advance drug compounds and drug delivery methods. It also focuses on product development programs in partnership with various leading pharmaceutical companies including Teva and AMAG. The company has a presence in the US and Switzerland. Antares Pharma is headquartered in Ewing, New Jersey, the US.

Antares Pharma Inc Key Recent Developments

Mar 03,2020: Antares Pharma reports fourth quarter and full year 2019 operating and financial results
Feb 25,2020: Antares Pharma To Report Fourth Quarter And Full Year 2019 Financial And Operating Results
Jan 27,2020: Antares Pharma announces full-year 2020 net revenue guidance range of $135 to $155 million

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Antares Pharma Inc – Key Facts
Antares Pharma Inc – Key Employees
Antares Pharma Inc – Key Employee Biographies
Antares Pharma Inc – Major Products and Services
Antares Pharma Inc – History
Antares Pharma Inc – Company Statement
Antares Pharma Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Antares Pharma Inc – Business Description
Business Segment: Licensing and Development
Performance
Business Segment: Product Sales
Performance
Business Segment: Royalties
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other
Performance
Geographical Segment: The US
Performance
R&D Overview
Antares Pharma Inc – Corporate Strategy
Antares Pharma Inc – SWOT Analysis
SWOT Analysis – Overview
Antares Pharma Inc – Strengths
Antares Pharma Inc – Weaknesses
Antares Pharma Inc – Opportunities
Antares Pharma Inc – Threats
Antares Pharma Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Antares Pharma Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 03, 2020: Antares Pharma reports fourth quarter and full year 2019 operating and financial results
Jan 27, 2020: Antares Pharma announces full-year 2020 net revenue guidance range of $135 to $155 million
Dec 10, 2019: Antares Pharma appoints Edward Tykot senior vice president, corporate development
Nov 20, 2019: Idorsia and Antares partner on auto-injector for AMI drug selatogrel
Nov 05, 2019: Antares Pharma reports third quarter 2019 operating and financial results
Oct 24, 2019: Antares Pharma announces two poster presentations at the 2019 Sexual Medicine Society Scientific Annual Meeting
Aug 06, 2019: Antares Pharma reports second quarter 2019 operating and financial results
Jun 27, 2019: Antares Pharma announces amendment to existing loan and security agreement with Hercules Capital
May 02, 2019: Antares Pharma reports first quarter 2019 operating and financial results
Mar 04, 2019: Antares Pharma announces board changes
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Antares Pharma Inc, Key Facts
Antares Pharma Inc, Key Employees
Antares Pharma Inc, Key Employee Biographies
Antares Pharma Inc, Major Products and Services
Antares Pharma Inc, History
Antares Pharma Inc, Other Locations
Antares Pharma Inc, Subsidiaries
Antares Pharma Inc, Key Competitors
Antares Pharma Inc, Ratios based on current share price
Antares Pharma Inc, Annual Ratios
Antares Pharma Inc, Annual Ratios (Cont...1)
Antares Pharma Inc, Interim Ratios
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Antares Pharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Antares Pharma Inc, Performance Chart (2015 - 2019)
Antares Pharma Inc, Ratio Charts
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Antares Pharma Inc (ATRS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CIMB Private Banking:企業の戦略・SWOT・財務情報
    CIMB Private Banking - Strategy, SWOT and Corporate Finance Report Summary CIMB Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Amsted Industries Inc:企業の戦略・SWOT・財務分析
    Amsted Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Amsted Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Holland Board of Public Works:企業の戦略的SWOT分析
    Holland Board of Public Works - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Marquette Capital Partners LLC:企業の戦略・SWOT・財務分析
    Marquette Capital Partners LLC - Strategy, SWOT and Corporate Finance Report Summary Marquette Capital Partners LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Janus Henderson Group Plc:企業の戦略・SWOT・財務情報
    Janus Henderson Group Plc - Strategy, SWOT and Corporate Finance Report Summary Janus Henderson Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates:企業の戦略・SWOT・財務分析
    Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates - Strategy, SWOT and Corporate Finance Report Summary Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • VentriPoint Inc:製品パイプライン分析
    Summary VentriPoint Inc (VentriPoint), a subsidiary of VentriPoint Diagnostics Ltd is a medical device company that manufactures and distributes medical devices for the cardiovascular market. The company’s product VMS is a heart visualization system which is used to evaluate right heart function. It …
  • SGL Carbon SE (SGL):企業の財務・戦略的SWOT分析
    SGL Carbon SE (SGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Swift Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Swift Biosciences Inc (Swift Biosciences) is a biotechnology company that develops novel research reagents, protocols, and molecular diagnostic tools. The company’s products include 2S hyb DNA library kit, 2S plus DNA library kit, 2S PCR-free DNA library kit, methyl-seq DNA library kit, DNA …
  • Cummins Inc (CMI)-エネルギー分野:企業M&A・提携分析
    Summary Cummins Inc. (Cummins) is a manufacturer of diesel engines and related technologies. It designs, manufactures, services and distributes engines and related component solutions. The company offers filtration, fuel systems, control systems, after treatment devices, turbochargers, air handling …
  • Moog Inc.:企業の戦略・SWOT・財務情報
    Moog Inc. - Strategy, SWOT and Corporate Finance Report Summary Moog Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • National Health Insurance Company – Daman PJSC:企業の戦略・SWOT・財務情報
    National Health Insurance Company - Daman PJSC - Strategy, SWOT and Corporate Finance Report Summary National Health Insurance Company - Daman PJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • ProSciento Inc-医療機器分野:企業M&A・提携分析
    Summary ProSciento Inc (ProSciento), formerly Profil Institute for Clinical Research Inc is contract research organization that concentrates on developing drugs and devices for the treatment of obesity, diabetes and metabolic diseases. The organization offers services such as clinical development an …
  • First Quantum Minerals Ltd:戦略・SWOT・企業財務分析
    First Quantum Minerals Ltd - Strategy, SWOT and Corporate Finance Report Summary First Quantum Minerals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Haoma Mining NL:企業の戦略・SWOT・財務情報
    Haoma Mining NL - Strategy, SWOT and Corporate Finance Report Summary Haoma Mining NL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Nano-Terra Inc-製薬・医療分野:企業M&A・提携分析
    Summary Nano-Terra Inc (Nano-Terra) is a clean technology company that develops and commercializes nano technology products. The company’s products include coating, advanced materials, organic and inorganic molecules, materials, polymers and UV water filtration system. It provides surface science, c …
  • Nippon Telegraph and Telephone Corporation:企業の戦略・SWOT・財務分析
    Nippon Telegraph and Telephone Corporation - Strategy, SWOT and Corporate Finance Report Summary Nippon Telegraph and Telephone Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Brown-Forman Corporation:企業の戦略・SWOT・財務分析
    Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report Summary Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • PricewaterhouseCoopers LLP (UK):企業の戦略的SWOT分析
    PricewaterhouseCoopers LLP (UK) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Biomerica Inc (BMRA):企業の財務・戦略的SWOT分析
    Biomerica Inc (BMRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆